IFNG and COVID-19: Importantly, functional experiments with K562 cells showed that NK-cell IFNγ production was significantly reduced in COVID-19 patients compared with healthy donors (Fig. 3b), which was predominantly observed in the CD56bright population associated with a significant reduction in degranulation activity (Fig. 3c).